At 3.3% CAGR, the South America Cardiopulmonary Oxygenator market is projected to be worth US$ 53.49 million by 2028, says The Business Market Insights

According to the Business Market Insights’ research, the South America cardiopulmonary oxygenator market was valued at US$ 44.13 million in 2022 and is expected to reach US$ 53.49 million by 2028, registering a CAGR of 3.3% from 2022 to 2028. Rise in incidence of cardiopulmonary diseases and increasing surgical procedures with surging in aging population are the critical factors attributed to the South America cardiopulmonary oxygenator market expansion.

Cardiopulmonary disorders mainly affect the lungs and heart of people. These conditions are categorized as cardiovascular diseases and chronic obstructive pulmonary disease (COPD). Cardiovascular diseases include coronary artery diseases, blood vessel diseases, heart arrhythmia problems, and heart defects, which affect the heart and blood vessels. Further, COPDs are diagnosed with emphysema and chronic bronchitis.

According to the World health organization (WHO), COPD was the third prominent cause of death worldwide in 2021. The high mortality rate of COPD is associated with acute exacerbations that lead to the failure of patients’ respiratory muscles, resulting in the loss of their ability to breathe independently; thus, the patients die from systemic infection and asphyxia. Oxygenator devices can be used to manage COPD attacks. Thus, with the growing incidence of COPD, the demand for cardiopulmonary oxygenators is also on the rise.

The primary risk factors of CVDs include family history, ethnicity, and age; other risk factors include tobacco consumption, hypertension, obesity, high cholesterol, physical inactivity, and diabetes. The WHO estimates 17.9 million lives are lost due to CVDs annually. To prevent patients’ death, oxygenator devices can be a major assistance to doctors. In the case of heart failure, the oxygen level in the blood is maintained with the help of an external device as the heart cannot maintain proper oxygen levels. Oxygenator devices are used to manage heart failure patients.

Thus, the increasing prevalence of cardiopulmonary diseases (cardiovascular disorders and COPDs) boosts the demand for cardiopulmonary oxygenators.

On the contrary, lack of skilled professionals hurdles the growth of South America cardiopulmonary oxygenator market.

Based on product, the South America cardiopulmonary oxygenator market is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held 91.3% market share in 2022, amassing US$ 40.30 million. It is projected to garner US$ 49.34 million by 2028 to expand at 3.4% CAGR during 2022–2028.

Based on application, the South America cardiopulmonary oxygenator market is bifurcated into cardiac and respiratory. The cardiac segment held 67.9% market share in 2022, amassing US$ 29.95 million. It is projected to garner US$ 37.67 million by 2028 to expand at 3.9% CAGR during 2022–2028. Further, cardiac is segmented into acute myocardial infarction, myocarditis, post-transplant complications, decompensated cardiomyopathy, and others. Further, respiratory is segmented into respiratory failure, acute respiratory distress syndrome, pulmonary embolism, pneumonia, and COVID-19.

Based on type, the South America cardiopulmonary oxygenator market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held 91.5% market share in 2022, amassing US$ 40.36 million. It is projected to garner US$ 49.14 million by 2028 to expand at 3.3% CAGR during 2022–2028.

Based on Age Group, the South America cardiopulmonary oxygenator market is segmented into adults, pediatric, and neonates. The adults segment held 72.2% market share in 2022, amassing US$ 31.86 million. It is projected to garner US$ 38.99 million by 2028 to expand at 3.4% CAGR during 2022–2028.

Based on end use, the South America cardiopulmonary oxygenator market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held 80.2 share in North America Cardiopulmonary Oxygenator market in 2022, amassing US$ 35.41 million. It is projected to garner US$ 43.27 million by 2028 to expand at 3.4% CAGR during 2022–2028.     

Based on country, the South America cardiopulmonary oxygenator market has been categorized into Brazil, Argentina and the Rest of South America.  Our regional analysis states that Brazil captured 57.0% market share in 2022. It was assessed at US$ 25.17 million in 2022 and is likely to hit US$ 31.19 million by 2028, exhibiting a CAGR of 3.6% during the forecast period.     

Key players dominating the South America cardiopulmonary oxygenator market are Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Nipro Medical Corp; Microport Scientific Corp; Braile Biomedica Industry, Commerce and Representation Ltd; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA among others.   

• In Nov 2022, LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support System.  
• In Feb 2020, FDA clears Fresenius Medical Care’s Novalung for treatment of acute respiratory and cardiopulmonary failure

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com